Novartis Receives FDA Complete Response Letter on Inclisiran ...Middle East

Medscape - News
The FDA was unable to approve the new drug application for inclisiran, a novel treatment to lower LDL cholesterol, owing to unresolved facility inspection concerns, the company said. News Alerts

Read More Details
Finally We wish PressBee provided you with enough information of ( Novartis Receives FDA Complete Response Letter on Inclisiran )

Apple Storegoogle play

Also on site :

Most viewed in News


Latest News